Literature DB >> 12015738

Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue.

G P Skliris1, A T Parkes, J L Limer, S E Burdall, P J Carder, V Speirs.   

Abstract

Two oestrogen receptors, ER alpha and ER beta, exist. While much is known about ER alpha, the role of ER beta is still undefined, especially at the protein level. The aim of this study was to determine the utility of seven ER beta antibodies (14C8, 8D5, PAI313, PPG5/10, N19, 9.88, and D7N) raised against different domains of ER beta in three commonly used laboratory applications, namely immunohistochemistry, western blot, and flow cytometry, using human breast material. For immunohistochemical analysis of frozen material, PAI313 and D7N gave stronger and more specific signals than 14C8, 8D5, and PPG5/10. In paraffin sections, 14C8, closely followed by PPG5/10, gave by far the most superior nuclear immunoreactivity, compared with the other antibodies tested. In general, flow cytometry results mirrored the immunohistochemistry data for paraffin sections, with antibodies ranked 14C8 > 8D5> or = PAI-313 > PPG5/10 >D7N. For western blotting, 8D5 and D7N yielded the strongest and most consistent bands, with weaker bands seen with the others. It is concluded that ER beta protein can be detected using specific antibodies. However, there is considerable variation between the specificity and application of these antibodies, highlighting the fact that careful optimization is required when selecting an antibody for use in a particular laboratory technique. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015738     DOI: 10.1002/path.1077

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  44 in total

1.  Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.

Authors:  Sri Navaratnam; Georgios Skliris; Gefei Qing; Shantanu Banerji; Ketan Badiani; Dongsheng Tu; Penelope A Bradbury; Natasha B Leighl; Frances A Shepherd; Janet Nowatzki; Alain Demers; Leigh Murphy
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

2.  C-28/I2 and T/C-28a2 chondrocytes as well as human primary articular chondrocytes express sex hormone and insulin receptors--Useful cells in study of cartilage metabolism.

Authors:  Horst Claassen; Martin Schicht; Jörg Brandt; Katharina Reuse; Ricarda Schädlich; Mary B Goldring; Saskia Sabrina Guddat; Annett Thate; Friedrich Paulsen
Journal:  Ann Anat       Date:  2010-10-25       Impact factor: 2.698

Review 3.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

4.  Development and Characterization of Novel Rat Anti-mERβ Sera.

Authors:  Horacio J Novaira; J B Graceli; S Capellino; A Schoeffield; G E Hoffman; A Wolfe; F Wondisford; S Radovick
Journal:  Endocrinology       Date:  2016-04-22       Impact factor: 4.736

5.  Immunohistochemical analysis of desmoid tumours.

Authors:  A Leithner; M Gapp; R Radl; A Pascher; P Krippl; K Leithner; R Windhager; A Beham
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

6.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 7.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

8.  Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.

Authors:  Erin K Shanle; Adedayo A Onitilo; Wei Huang; KyungMann Kim; Chong Zang; Jessica M Engel; Wei Xu; Kari B Wisinski
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

9.  A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

Authors:  Flavia Novelli; Michele Milella; Elisa Melucci; Anna Di Benedetto; Isabella Sperduti; Raffaele Perrone-Donnorso; Letizia Perracchio; Irene Venturo; Cecilia Nisticò; Alessandra Fabi; Simonetta Buglioni; Pier Giorgio Natali; Marcella Mottolese
Journal:  Breast Cancer Res       Date:  2008-09-04       Impact factor: 6.466

10.  The evolving role of oestrogen receptor beta in clinical breast cancer.

Authors:  Valerie Speirs
Journal:  Breast Cancer Res       Date:  2008-09-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.